Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

720541

registered interest
date	13/04/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Licensing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what factors will be measured to monitor patient access to treatment after the introduction of the NICE and NHS England joint changes to technology appraisals and highly specialised technologies reforms.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	70639
answer	answer is ministerial correction date of answer 20/04/2017 answer text <p>The National Institute for Health and Care Excellence (NICE) and NHS England will use standard systems already in place to measure access to treatments. In addition, NICE and NHS England have committed to review the impact of the changes to the arrangements for the assessment and adoption of new treatments three years after their implementation.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 20/04/2017 10:38:33 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4056 label Biography information for Nic Dakin

720542

registered interest
date	13/04/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Licensing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment has been made of whether there have been delays to patient access to treatment as a result of the proposals being implemented by the NICE and NHS England joint changes to technology appraisals and highly specialised technologies.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	70640
answer	answer is ministerial correction date of answer 20/04/2017 answer text <p>The changes to technology appraisals and highly specialised technologies are being implemented for topics with a first evidence submission to the National Institute for Health and Care Excellence (NICE) after 1 April. It is therefore too soon for products under the new arrangements to have received their final guidance from NICE.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 20/04/2017 10:40:21 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4056 label Biography information for Nic Dakin

714576

registered interest
date	28/03/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Nivolumab: Hodgkin Lymphoma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the clinical benefits of nivolumab for patients with relapsed or refractory classical Hodgkin lymphoma.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	69561
answer	answer is ministerial correction date of answer 18/04/2017 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing robust, evidence based guidance for the National Health Service on the clinical and cost effectiveness of drugs and other treatments. NICE is currently appraising nivolumab for use in the treatment of relapsed or refractory classical Hodgkin lymphoma. NICE published its draft guidance for consultation on 14 March and stakeholders had until 3 April to comment. NICE currently expects to publish final guidance in July 2017.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 18/04/2017 13:47:53 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4056 label Biography information for Nic Dakin

714578

registered interest
date	28/03/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hodgkin Lymphoma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the availability of treatment options for patients with classical Hodgkin lymphoma whose disease has progressed or not responded to standard of care treatments.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	69562
answer	answer is ministerial correction date of answer 18/04/2017 answer text <p>NHS England has advised that there are two main drugs that are currently licensed for the treatment of patients who have failed standard therapies for their Hodgkin lymphoma; brentuximab and nivolumab.</p><p> </p><p>Brentuximab is currently available through the Cancer Drugs Fund for the treatment of patients with relapsed or refractory CD30 positive Hodgkin’s lymphoma. The National Institute for Health and Care Excellence (NICE) is currently appraising brentuximab and expects to publish final guidance in May 2017.</p><p> </p><p>Nivolumab is licensed for patients with Hodgkin lymphoma who have progressed despite an autologous stem cell transplant and who have also received treatment with brentuximab. NICE is currently appraising nivolumab for use in this indication and expects to publish final guidance in July 2017. Nivolumab is not currently funded routinely in this indication.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 18/04/2017 13:46:18 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4056 label Biography information for Nic Dakin

714580

registered interest
date	28/03/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Nivolumab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions his Department has had with NICE on that body's decision not to recommend nivolumab for treating relapsed or refractory classical Hodgkin lymphoma and the suitability of methods of appraisal used to assess blood cancer medicines which treat small patient populations.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	69563
answer	answer is ministerial correction date of answer 18/04/2017 answer text <p>The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for the methods and processes it uses in the development of its guidance, which are developed through extensive engagement with stakeholders and periodically reviewed to ensure they remain appropriate. NICE has been able to recommend a number of drugs for the treatment of blood cancers for small patient populations through its technology appraisal programme.</p><p> </p><p>NICE has not yet published final guidance on the use of nivolumab for the treatment of relapsed or refractory classical Hodgkin lymphoma and stakeholders had until 3 April to comment on NICE’s draft recommendations.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 18/04/2017 13:44:19 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4056 label Biography information for Nic Dakin

712980

registered interest
date	21/03/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Exercise: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether he plans to launch the Daily Mile nationwide in England.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	68767
answer	answer is ministerial correction date of answer 24/03/2017 answer text <p>The Chief Medical Officer recommends that all children aged five-18 should get at least 60 minutes of moderate to vigorous physical activity each day.</p><p> </p><p>The Government published a Childhood Obesity Plan for Action in August 2016, which can be accessed here:</p><p><a href="https://www.gov.uk/government/publications/childhood-obesity-a-plan-for-action" target="_blank">https://www.gov.uk/government/publications/childhood-obesity-a-plan-for-action</a></p><p> </p><p>This plan states that for all primary school children, at least 30 minutes of physical activity should be delivered in school every day through active break times, Physical Education, extra curricular clubs, active lessons or other sport and physical activity events. Schools have the freedom to decide how to meet this expectation and which programmes, such as The Daily Mile, they choose to adopt.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 24/03/2017 11:38:12 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4056 label Biography information for Nic Dakin

713017

registered interest
date	21/03/2017
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Personal Independence Payment: Appeals
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Justice, how many people who appealed to a tribunal against a decision not to award the enhanced rate mobility component of personal independence payments were awarded (a) the standard rate, (b) the enhanced rate and (c) nothing in each quarter of 2016.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	68658
answer	answer is ministerial correction date of answer 24/03/2017 answer text <p>This information is not held centrally.</p><p> </p><p>Information about the number and outcomes of Personal Independence Payment appeals generally is published on gov.uk. The most recent statistics, for the period October to December 2016, can be viewed at <a href="http://www.gov.uk/government/statistics/tribunals-and-gender-recognition-certificate-statistics-quarterly-october-to-december-2016" target="_blank">www.gov.uk/government/statistics/tribunals-and-gender-recognition-certificate-statistics-quarterly-october-to-december-2016</a></p> answering member constituency North East Hertfordshire answering member printed Sir Oliver Heald grouped question UIN 68659 question first answered 24/03/2017 14:19:06 answering member 69 label Biography information for Sir Oliver Heald
tabling member	4056 label Biography information for Nic Dakin

713018

registered interest
date	21/03/2017
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Personal Independence Payment: Appeals
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Justice, how many people who appealed to a tribunal against a decision not to award the standard rate mobility component of personal independence payments were awarded (a) the standard rate, (b) the enhanced rate and (c) nothing in each quarter of 2016.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	68659
answer	answer is ministerial correction date of answer 24/03/2017 answer text <p>This information is not held centrally.</p><p> </p><p>Information about the number and outcomes of Personal Independence Payment appeals generally is published on gov.uk. The most recent statistics, for the period October to December 2016, can be viewed at <a href="http://www.gov.uk/government/statistics/tribunals-and-gender-recognition-certificate-statistics-quarterly-october-to-december-2016" target="_blank">www.gov.uk/government/statistics/tribunals-and-gender-recognition-certificate-statistics-quarterly-october-to-december-2016</a></p> answering member constituency North East Hertfordshire answering member printed Sir Oliver Heald grouped question UIN 68658 question first answered 24/03/2017 14:19:06 answering member 69 label Biography information for Sir Oliver Heald
tabling member	4056 label Biography information for Nic Dakin

709036

registered interest
date	07/03/2017
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Personal Independence Payment: Appeals
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Justice, what the average waiting time is for an appeal against a mandatory reconsideration of a decision on personal independence payments in (a) Scunthorpe and (b) England for the last four periods for which figures are available.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	66786
answer	answer is ministerial correction date of answer 14/03/2017 answer text <p>The information requested is set out below.</p><table><tbody><tr><td colspan="3"><p><strong> </strong> <strong>Average waiting time in weeks for the disposal of Personal Independence Payment </strong><sup>1</sup> <strong> appeals from receipt to outcome</strong><strong><sup>2</sup></strong> <strong>for the last four quarterly periods (January – December 2016) </strong></p></td></tr><tr><td><p> </p></td><td><p><strong>Doncaster </strong><strong><sup>3</sup></strong></p></td><td><p><strong>England</strong></p></td></tr><tr><td><p>January – March 2016</p></td><td><p>21</p></td><td><p>16</p></td></tr><tr><td><p>April – June 2016</p></td><td><p>19</p></td><td><p>15</p></td></tr><tr><td><p>July – September 2016</p></td><td><p>15</p></td><td><p>15</p></td></tr><tr><td><p>October – December 2016</p></td><td><p>15</p></td><td><p>16</p></td></tr></tbody></table><p> </p><p>SSCS data are attributed to the hearing venue nearest to the appellant’s home address. If the case goes to an oral hearing, the location of the Tribunal hearing venue is normally nearest to the appellant’s home address. We cannot retrieve data based on the appellants actual address, but can produce reports detailing the numbers of cases that were dealt with at one of our Regional centres or heard at a specific venue.</p><p> </p><p><sub>1</sub> Personal Independence Payment (New Claim Appeals), which replaced Disability Living Allowance and was introduced on 8 April 2013, also includes Personal Independence Claims (Reassessments).</p><p><sub>2 </sub>Outcome: All appeals disposed of include those appeals disposed of with and without a tribunal hearing.</p><p><sub>3 </sub>Covers all appeals heard at the Doncaster Venue which serves appellants living in Scunthorpe.</p> answering member constituency North East Hertfordshire answering member printed Sir Oliver Heald question first answered 14/03/2017 17:12:29 answering member 69 label Biography information for Sir Oliver Heald
tabling member	4056 label Biography information for Nic Dakin

709064

registered interest
date	07/03/2017
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Personal Independence Payment: Appeals
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, pursuant to the Answer of 2 March 2017 to Question 64658, on personal independence payments, what options his Department is considering to better support disabled people with Motability vehicles who are waiting in excess of seven weeks for mandatory reconsiderations.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	66783
answer	answer is ministerial correction date of answer 15/03/2017 answer text <p>The Government is always exploring new ways to support disabled people, including those making PIP appeals. We have had a range of discussions with Motability and other relevant departments, and any announcement regarding the progress of these discussions will be made publicly by the Government in due course.</p> answering member constituency Portsmouth North answering member printed Penny Mordaunt question first answered 15/03/2017 14:16:27 answering member 4017 label Biography information for Penny Mordaunt
tabling member	4056 label Biography information for Nic Dakin